FR2700115B1 - Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. - Google Patents

Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.

Info

Publication number
FR2700115B1
FR2700115B1 FR9305123A FR9305123A FR2700115B1 FR 2700115 B1 FR2700115 B1 FR 2700115B1 FR 9305123 A FR9305123 A FR 9305123A FR 9305123 A FR9305123 A FR 9305123A FR 2700115 B1 FR2700115 B1 FR 2700115B1
Authority
FR
France
Prior art keywords
convulsants
parkinson
disease
treatment
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9305123A
Other languages
English (en)
Other versions
FR2700115A1 (fr
Inventor
Alain Boireau
Adam Doble
Pierre Dubedat
Erik Louvel
Mireille Meunier
Jean-Marie Miquet
Jean-Marie Stutzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9300074A external-priority patent/FR2700117B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9305123A priority Critical patent/FR2700115B1/fr
Publication of FR2700115A1 publication Critical patent/FR2700115A1/fr
Application granted granted Critical
Publication of FR2700115B1 publication Critical patent/FR2700115B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9305123A 1993-01-07 1993-04-30 Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. Expired - Fee Related FR2700115B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9305123A FR2700115B1 (fr) 1993-01-07 1993-04-30 Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9300074A FR2700117B1 (fr) 1993-01-07 1993-01-07 Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR9305123A FR2700115B1 (fr) 1993-01-07 1993-04-30 Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.

Publications (2)

Publication Number Publication Date
FR2700115A1 FR2700115A1 (fr) 1994-07-08
FR2700115B1 true FR2700115B1 (fr) 1995-02-03

Family

ID=26230011

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9305123A Expired - Fee Related FR2700115B1 (fr) 1993-01-07 1993-04-30 Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.

Country Status (1)

Country Link
FR (1) FR2700115B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action

Also Published As

Publication number Publication date
FR2700115A1 (fr) 1994-07-08

Similar Documents

Publication Publication Date Title
IT9083334A0 (it) Procedimento per l'estrazione e la purificazione di dna genomico umano
NZ289028A (en) Use of antisense nucleic acids in the treatment of skin disease
ZA931174B (en) Treatment of disease employing hyaluronic acid and nsaids.
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
AU1595088A (en) Kernel oils and disease treatment
FR2680103B1 (fr) Utilisation en cosmetique ou en pharmacie d'alkylpolyglycosides et/ou de derives o-acyles du glucose pour le traitement de la chute des cheveux.
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
AU2729400A (en) Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
FR2700115B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
BR9105800A (pt) Processo de "polimento" de granulados de principios ativos alimentares e/ou medicamentosos e granulados de principios ativos
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
FR2756737B1 (fr) Application de la thalidomide au traitement de la maladie de parkinson et des syndromes parkinsoniens
FR2774596B1 (fr) Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
FR2741804B1 (fr) Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
EP0666745A4 (fr) Procedes de diagnostic et de traitement de la maladie de parkinson.
FR2702149B1 (fr) Application de la lamotrigine dans le traitement du neuro-sida.
FR2709964B1 (fr) Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès.
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
FR2710266B1 (fr) Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.
FR2702151B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
AU1760295A (en) Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
ZA97902B (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis.

Legal Events

Date Code Title Description
ST Notification of lapse